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Abstract
Background: Phyllodes tumors (cystosarcoma phyllodes) are uncommon lesions in the female
breast. Rarely, the occurrence of carcinoma within a phyllodes tumor has been reported in the
literature, but has never been associated with lymph node metastases.
Case presentation: A 26-year-old woman presented with a firm, mobile, non-tender mass in the
left breast and palpable lymph nodes in the left axilla. The excised lesion appeared well
circumscribed and lobulated, with variable fleshy and firm areas. Microscopic examination showed
a circumscribed fibroepithelial lesion with a well developed leaf-like architecture, in keeping with a
benign phyllodes tumor. The epithelial component showed extensive high grade ductal carcinoma
in-situ (DCIS) and invasive carcinoma of no special type, located entirely within the phyllodes tumor.
Subsequent axillary lymph node dissection revealed metastatic carcinoma in four lymph nodes.
Conclusions: Although rare, phyllodes tumors may harbor DCIS and invasive carcinoma, with
potential for lymph node metastasis.
Background
Phyllodes tumors constitute less than 1% of breast tumors
and 2–3% of fibroepithelial breast tumors [1]. They usu-
ally occur in middle-aged to elderly women but can occur
at any age. No single feature is reliable in predicting clini-
cal behavior of phyllodes tumors. Several histological
parameters should be evaluated, including stromal cellu-
larity, atypia, mitoses, stromal overgrowth, infiltrative
borders, and presence or absence of necrosis [1,2]. A
mitotic rate of less than 5 per 10 high power field (HPF)
suggests benign behavior, while a mitotic figure rate of
more than 10 per 10 HPF suggests malignant potential
[2,3]. Most of these tumors are benign, but up to 30%
show malignant stroma [4]. Metastases, usually hematog-
enous rather than lymphatic, have been reported to occur
at a rate of 13% in 10 years for malignant phyllodes
tumors [4]. As malignant phyllodes tumors usually spread
by a hematogenous rather than a lymphatic route, axillary
lymph node dissection is generally not recommended.
Importantly, local recurrences are common even in
benign tumors and are seen in up to 8% in 10 years [4].
We describe a case of in-situ and invasive carcinoma occur-
ring within a benign phyllodes tumor in a 26-year-old
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ing age for this combination tumor. We also report the
first case of this combination tumor with documented
lymph node metastases. Our case highlights the impor-
tance of assessing phyllodes tumors for concurrent carci-
nomatous involvement, as this may affect both the need
for axillary lymph node examination and subsequent
treatment options.
Case presentation
A 26-year-old woman presented with a 1 month history of
a palpable mass in her left breast. Her mother died at the
age of 31 years of breast cancer. Examination revealed a 2
cm firm and mobile mass in the lower outer quadrant of
the left breast. The left axilla contained two enlarged pal-
pable lymph nodes.
Mammography showed a 2 cm oval density that was
homogenous with sharp margins. Ultrasound character-
ized the mass as solid but with a complex internal archi-
tecture. Fine needle aspiration of the mass was performed.
It was positive for carcinoma, showing a very cellular sam-
ple with many malignant epithelial cells in cohesive
groups, as well as lying singly in a background of necrosis
and inflammation. The surgeon subsequently performed
an excisional biopsy.
Low power photomicrograph of the phyllodesFigure 1
Low power photomicrograph of the phyllodes tumor: Histologically, the neoplasm was biphasic, with proliferating stroma, 
compressed glands, and a well developed leaf-like architecture (H&E, original magnification 40×).Page 2 of 6
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cm and appeared well circumscribed. The cut surface was
grey and lobulated with variable fleshy and firm areas.
Histological examination revealed a well-circumscribed
biphasic neoplasm, consisting of proliferating stroma and
compressed glands, displaying a well developed leaf-like
architecture. The stroma was moderately cellular, mildly
vascular, and lacked cytological atypia, mitoses, and stro-
mal overgrowth. The features were consistent with a
benign phyllodes tumor (figures 1 &2). More impor-
tantly, the epithelial component of the phyllodes tumor
showed extensive ductal carcinoma in-situ, with multiple
foci of invasive mammary carcinoma (figure 3). The DCIS
was of high nuclear grade, cribriform and micropapillary
architecture, with (comedo-type) necrosis (figure 4). The
invasive carcinoma was of no special type, SBR Grade III/
III (Score 8/9). Multiple tumor emboli were present
within endothelial-lined spaces adjacent to the tumor, but
the surrounding breast was otherwise unremarkable.
Although the carcinomatous component was confined to
the phyllodes tumor, the lesion was <1 mm from the near-
est resection margin. Immunohistochemistry using
smooth muscle myosin heavy chain and muscle specific
actin demonstrated absence of the myoepithelial cell layer
within areas of invasive carcinoma, and focal loss within
areas of DCIS. There was intensely positive staining within
High power photomicrograph of the phyllodesFi ure 2
High power photomicrograph of the phyllodes tumor: The stroma lacked cellular atypia and mitoses, consistent with a benign 
phyllodes tumor (H&E, original magnification 400×).Page 3 of 6
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receptors.
The patient went on to have a left axillary lymph node dis-
section and subsequent pathological examination
revealed 4 of 13 nodes positive for metastatic adenocarci-
noma. She received adjuvant CEF (Cyclophosphamide,
Epirubicin, 5-Fluorouracil) chemotherapy and underwent
further local excision to achieve wider margins; patholog-
ical examination was negative for residual tumor. She sub-
sequently received local radiation and is currently
undergoing tamoxifen therapy. The patient is presently
alive and disease free, nearly three years after presentation.
Discussion
The epithelial component of phyllodes tumors (whether
benign or malignant) may show a range of metaplastic
(apocrine, squamous) and proliferative changes [5,6].
However, carcinoma arising within a phyllodes tumor is
decidedly rare, with less than 30 reported cases in the lit-
erature. The age of the previously reported patients with
coexistent carcinoma and phyllodes tumor ranged from
31–80 years, with most of the patients in the 5th or 6th
decades [7,8]. This case represents the youngest age at
presentation with this combination tumor. The reported
subtypes include in-situ and invasive lobular and ductal
(no special type) carcinoma, tubular carcinoma and squa-
Photomicrograph of the carcinomatous componentFigure 3
Photomicrograph of the carcinomatous component: The epithelial component showed DCIS and invasive mammary carcinoma 
(H&E, original magnification 100×).Page 4 of 6
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greater atypia in epithelial components of recurrent phyl-
lodes tumors. Squamous carcinoma, typically rare in the
breast, seems to occur more often in phyllodes tumors,
compared to patients without phyllodes tumors [10].
The prognosis for cases of carcinoma within phyllodes
tumors is generally favorable, with no deaths yet reported
[9,10]. The stroma is benign in the majority and cancer
detection often occurs early because the patient presents
with a rapidly enlarging mass [10]. Our case appears to
represent the first documentation of lymph node spread
of the carcinomatous component from within a phyllodes
tumor. Axillary lymph node dissection is not part of the
standard treatment for phyllodes tumors as lymph node
spread is rare [14]. Several authors have suggested treating
carcinoma within phyllodes tumors according to the car-
cinomatous component [9,14]. Our case supports this
view, particularly with respect to the need for assessment
of axillary lymph node status in determining prognosis
and treatment.
Conclusions
Invasive carcinoma occurring within a phyllodes tumor is
rare; occurrence of axillary lymph node metastasis is even
rarer. Besides the stromal component, the epithelial com-
Photomicrograph of the DCIS patternsFigure 4
Photomicrograph of the DCIS patterns: The DCIS showed cribriform and micropapillary architecture, with necrosis (H&E, 
original magnification 100×).Page 5 of 6
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ponent of phyllodes tumors should also be examined in
detail, as it may harbor an in situor invasive carcinoma.
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